Aurinia Pharmaceuticals
AUPH
AUPH
167 hedge funds and large institutions have $678M invested in Aurinia Pharmaceuticals in 2021 Q1 according to their latest regulatory filings, with 44 funds opening new positions, 54 increasing their positions, 47 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
4.88% less ownership
Funds ownership: 45.86% → 40.97% (-4.9%)
16% less capital invested
Capital invested by funds: $803M → $678M (-$125M)
24% less call options, than puts
Call options by funds: $23.9M | Put options by funds: $31.4M
Holders
167
Holding in Top 10
3
Calls
$23.9M
Puts
$31.4M
Top Buyers
| 1 | +$46.1M | |
| 2 | +$17.1M | |
| 3 | +$7.68M | |
| 4 |
BC
Blackcrane Capital
Bellevue,
Washington
|
+$6.54M |
| 5 |
Fidelity International
Hamilton,
Bermuda
|
+$6.16M |
Top Sellers
| 1 | -$77.7M | |
| 2 | -$23.7M | |
| 3 | -$20.3M | |
| 4 |
ABG
Ally Bridge Group
New York
|
-$11.9M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$9.51M |